Voyageur Pharmaceuticals Ltd. (VM.V)

CAD 0.11

(50.0%)

Annual Income Statements

(In CAD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 2185.00 2908.00 2246.00 1483.00 2120.00 -
Gross Profit -2185.00 -2908.00 -2246.00 -1483.00 -2120.00 -
Operating Expenses 1.22 Million 1.75 Million 2.05 Million 1 Million 554.89 Thousand 866.02 Thousand
Selling, General and Administrative Expenses 1.22 Million 1.22 Million 1.55 Million 999.56 Thousand 552.77 Thousand 866.02 Thousand
Research and Development Expenses - 527.56 Thousand 496.51 Thousand - - -
Other Expenses - - - 13.72 Thousand 2600.00 26.87 Thousand
Cost and Expenses 1.22 Million 1.75 Million 2.05 Million 1 Million 554.89 Thousand 866.02 Thousand
Operating Income -1.22 Million -1.74 Million -2.05 Million -848.93 Thousand -554.89 Thousand -1.14 Million
Interest Expense - - 3277.00 18.64 Thousand - -
Income Tax Expense - 1969.00 -1.00 152.1 Thousand -169.74 Thousand -444.43 Thousand
Earnings before Tax -1.39 Million -1.75 Million -2.05 Million -1.13 Million -552.29 Thousand -555.86 Thousand
Net Income -1.39 Million -1.75 Million -2.05 Million -1.13 Million -552.29 Thousand -555.86 Thousand
Earnings Per Share Basic -0.01 -0.02 -0.02 -0.02 -0.01 -0.01
Earnings Per Share Diluted -0.01 -0.02 -0.02 -0.02 -0.01 -0.01
Weighted Average Shares Outstanding 130.51 Million 107.82 Million 94.67 Million 70.52 Million 57.53 Million 47.52 Million
Weighted Average Shares Outstanding (Diluted) 130.5 Million 107.82 Million 94.67 Million 70.52 Million 57.53 Million 47.52 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -1.22 Million -1.75 Million -2.04 Million -1.11 Million -550.17 Thousand -
Earnings Before Tax Margin - - - - - -

Income Statement Charts